It has been described that PTEN establishes direct contact with the glycolytic enzyme phosphoglycerate kinase 1 (PGK1), dephosphorylating it and inhibiting its autophosphorylation; ultimately PTEN inhibits glycolysis, ATP production and brain tumour cell proliferation (Qian et al., 2019). The gene discussed is PTEN; the disease is brain neoplasm.